Mode
Text Size
Log in / Sign up

RSVpreF

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of RSVpreF

5 trials tracked of RSVpreF: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 113 citations.

5Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 2 Phase 2 2 Phase 1 1
  1. Phase 3 A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. Completed · 113 cited
  2. Phase 3 A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease Completed · 23 cited
  3. Phase 2 A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). Completed
  4. Phase 2 Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults Completed
  5. Phase 1 A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.